Finance

NewTimeSpace News: On 20 August 2026, LUYE PHARMA (02186.HK) voluntarily announced that its therapeutic mRNA vaccine LY01620 is about to initiate a Phase II clinical trial in China for patients with HPV16-positive HSIL; the Phase I study showed an HPV viral clearance rate of nearly 90% and histological improvement approaching standard surgical levels, with the treatment being non-invasive and not affecting fertility.

NewTimeSpace · 2026-08-21

NewTimeSpace News: On 20 August 2026, HANKING GOLD (03788.HK) announced that Independent Non-Executive Director Wang Ping has been appointed as Senior Independent Non-Executive Director, effective 20 August 2026, primarily to facilitate communication among independent directors and with shareholders, especially minority shareholders; the position was introduced by reference to the amended Corporate Governance Code.

NewTimeSpace · 2026-08-21

NewTimeSpace News: On 21 August 2026, SIMCERE PHARMA (02096.HK) announced that Wan Yushan has ceased as Joint Company Secretary (remaining ED and CFO), with Board Secretary Zhu Da appointed in addition as his successor and granted a three-year waiver from company secretary qualification requirements (assisted by Mai Baowen); Mr. Zhu has over 12 years of investment banking and corporate management experience.

NewTimeSpace · 2026-08-21

NewTimeSpace News: On 21 August 2026, XIN YUAN ENT (01748.HK) announced that it submitted a resumption proposal to the Stock Exchange on 14 August 2026, with the forensic investigation and internal control review reports issued and all financial results published; the shares remain suspended since 21 February 2025 until the resumption guidance is fulfilled.

NewTimeSpace · 2026-08-21

NewTimeSpace News: On 21 August 2026, CSTONE PHARMA-B (02616.HK) voluntarily announced that the IND of CS5007, an EGFR/HER3 bispecific ADC, has been fast-tracked and approved by the NMPA in 23 working days; its global multi-center Phase I trial was initiated in Australia in June 2026 with the first patient enrolled, and approximately 310 patients are expected to be enrolled.

NewTimeSpace · 2026-08-21

NewTimeSpace News: On 21 August 2026, LONGBIO-B (01779.HK) voluntarily announced that the BLA of LP-003 for seasonal allergic rhinitis has been accepted by the NMPA; LP-003 is a novel anti-IgE antibody targeting multiple allergic diseases, and its IND application for peanut allergy was previously approved by the US FDA.

NewTimeSpace · 2026-08-21

NewTimeSpace News: On 20 August 2026, EMPEROR INT'L (00163.HK) agreed to sell a five-commercial-unit property of 15,788 square feet on San Ma Lo, Macau for HKD 106 million, with a deposit of HKD 20 million already paid and the balance of HKD 86 million payable upon completion, expecting to record a fair value loss of approximately HKD 14 million.

NewTimeSpace · 2026-08-20

NewTimeSpace News: On 20 August 2026, ENVISION GREEN (01783.HK) completed a placing of 117.9 million shares and a top-up subscription at HKD 4.66 per share, and completed the subscription of RMB 472 million convertible bonds bearing 5.00% interest per annum; combined net proceeds were approximately HKD 1,077.68 million, of which approximately 90% will fund the cloud computing and data centre acquisition and the AI server purchase.

NewTimeSpace · 2026-08-20

NewTimeSpace News: On 20 August 2026, ZGC TEC LEASING (01601.HK) participated in establishing a venture fund with registered capital of RMB 415 million, subscribing for 49.5% of its committed capital; the transaction, involving connected person Zhongguancun Xietong, constitutes a discloseable and connected transaction subject to independent shareholders' approval.

NewTimeSpace · 2026-08-20

NewTimeSpace News: On 20 August 2026, AIDIGONG (00286.HK) provided a quarterly update on its resumption progress; the 18-month delisting deadline expired the same day and an extension has been sought, the company has still not received financial information from Shenzhen AIDIGONG and remains non-compliant with several Listing Rules requirements, with trading suspended since 21 February 2025.

NewTimeSpace · 2026-08-20

NewTimeSpace News: On 20 August 2026, NOVATECH INTEL (08131.HK) announced that Ms. Zhang Jinping was appointed executive director and chief executive officer, Ms. Wang Yaping was appointed executive director, Mr. Zhou Weixing resigned as independent non-executive director, and Ms. Li Jing succeeded as independent non-executive director and chair of the three committees.

NewTimeSpace · 2026-08-20

NewTimeSpace News: On 20 August 2026, BJENERGY INTL (00686.HK) disclosed that Jingneng Smart Energy entered a comprehensive energy project agreement with Beijing University of Technology, with total construction investment of RMB 236.17 million and a 20-year operation period, constituting a discloseable transaction.

NewTimeSpace · 2026-08-20

NewTimeSpace News: On 20 August 2026, 51WORLD (06651.HK) established a joint venture with Shenzhen Union Vision and launched the embodied AI data platform AperData, which has received over 10,000 orders with first deliveries at the end of August 2026; the establishment does not constitute a notifiable transaction.

NewTimeSpace · 2026-08-20

NewTimeSpace News: On 20 August 2026, JLMAG (06680.HK) proposed reallocating USD 15 million of unutilised H-share convertible bond proceeds, with USD 6 million to debt repayment and USD 9 million to raw material procurement, subject to an ordinary resolution of shareholders; USD 55.33 million remains reserved for H-share buybacks after the change.

NewTimeSpace · 2026-08-20

NewTimeSpace News: On 20 August 2026, CHINA EB LTD (00165.HK) disclosed that the Chongqing Fifth Intermediate People's Court ordered it to pay RMB 1.367 billion in share transfer consideration for Yingli International Real Estate plus default interest at 5% per annum; the judgment remains within the appeal period and the company intends to appeal, with the total amount involved representing less than 10% of audited net assets.

NewTimeSpace · 2026-08-20

NewTimeSpace News: On 20 August 2026, MAOYAN ENT (01896.HK) entered an IP business cooperation framework agreement with China Literature Group covering IP development and joint investment, with a term to 31 December 2027, constituting a continuing connected transaction, with 2027 annual caps of RMB 30 million for licence fees and RMB 80 million for joint investment.

NewTimeSpace · 2026-08-20
Previous1..4748 495051..272     272 pages total